Text Size: A  A  A

ILAE
ILAE Logo
ILAE Search
ILAE

Epilepsia - Editor's Choice

May 2012 articles from Editor-in-Chief Phil Schwartzkroin

The system epilepsies: A pathophysiological hypothesis

Giuliano Avanzini, Paolo Manganotti, Stefano Meletti, Solomon L. Moshé, Ferruccio Panzica, Peter Wolf, Giuseppe Capovilla
Volume 53, Issue 5, pp 771-778, May 2012.

DOI: 10.1111/j.1528-1167.2012.03462.x published online April 25, 2012

The authors propose that some types of epilepsies - “system epilepsies” (SystE) - reflect the pathological expression of an identifiable neural system, made up of brain areas the integrated activities of which subserve normal physiological functions. As such, SystE lead to functional results that cannot be obtained by pathological activity within the individual elements alone.

The phenomenology associated with a given SystE is determined by a contextual involvement of the contributing structures, and therefore predictable according to the functional specialization of the involved system. The SystE hypothesis further postulates that the “enduring propensity to generate seizures” of some epilepsies is due to the specific susceptibility of a system as a whole, although it may be possible to identify some trigger areas within the system. The persistent susceptibility of the seizure-generating system is assumed to exist also in the interictal period.

The authors offer a number of examples of this provocative hypothesis, with absence epilepsy and juvenile myoclonic epilepsy providing the prototypes, and such developmental phenomena as West syndrome (with infantile spasms and hypsarrhythmia) described as potentially system epilepsies. It remains to be seen whether this hypothesis actually provides a productive new way of thinking about and investigating seizure types (and epilepsy syndromes), and whether this approach will result in new therapeutic perspectives.

Abstract | Full Text | PDF


Spatiotemporal neuronal correlates of seizure generation in focal epilepsy

Mark R. Bower, Matt Stead, Fredric B. Meyer, W. Richard Marsh, Gregory A. Worrell
Volume 53, Issue 5, pp 807–816, May 2012.

doi: 10.1111/j.1528-1167.2012.03417.x; published online February 21, 2012

Focal seizures are thought to reflect simultaneous activation of a large population of neurons within a discrete region of pathological brain. Despite a number studies focusing on single-neuron activity in patients with epilepsy, no study has examined long–term firing rates leading into seizures and the spatial relationship of unit activity with respect to the seizure onset zone. In this study, microelectrode arrays were used to record action potentials from neurons in mesial temporal structures (often including contralateral mesial temporal structures) in seven patients with mesial temporal lobe epilepsy.

Surprisingly, only about 8% of microelectrode sites showed increased neuronal firing rates prior to seizure onset, and only about a third of microelectrodes showed any seizure-related activity changes; the majority of microelectrodes (including some located within the seizure onset zone) showed no change throughout the seizure. Furthermore, changes in firing rate prior to and at seizure onset were observed on microelectrodes located outside the seizure onset zone and even in contralateral mesial temporal lobe.

These early changes varied from seizure to seizure, demonstrating the heterogeneity of ensemble activity underlying the generation of focal seizures. Increased neuronal synchrony was primarily observed only following seizure onset. These results challenge our current thinking about neuronal contributions to seizures. The data indicate that cellular contributions to seizure initiation and sustained ictal discharge in mesial temporal lobe epilepsy involve a small subset of the neurons within and outside the seizure onset zone. Further, the “epileptic ensemble” or “network” responsible for seizure generation appears to be quite complex and heterogeneous. This study indicates the need for a new conceptual understanding of seizure mechanisms, and perhaps for new therapeutic approaches that target neuronal activities outside the clinical seizure onset zone.

Abstract | Full Text | PDF


April 2012 articles from Editor-in-Chief Phil Schwartzkroin

The urinary safety profile and secondary renal effects of retigabine (ezogabine): A first-in- class antiepileptic drug that targets KCNQ (Kv7) potassium channels.

Brickel N, Gandhi P, VanLandingham K, Hammond J, DeRossett S (2012)
Volume 53, Issue 4, pp 606-612, April, 2012.

DOI: 10.1111/j.1528-1167.2012.03441.x; published online March 16, 2012

Retigabine (or ezogabine as it is known as in the US) is a new antiepileptic drug recently licensed in Europe and the USA. It is a potassium channel opener, enhancing the effects of KCNQ2/3 activity in the brain. It also has a pharmacological effect on urinary smooth bladder muscle, and so carries a risk of urinary side-effects, particularly urinary retention and urinary hesitation. Consequently, there has been much interest in the adverse event (AE) profile of RTG/EZG and the potential risk of effects on the urinary system.

This excellent and definitive review, from the medical team of GlaxoSmithCline and Valeant Pharmaceuticals, summarizes the urinary safety profile, based on data from the 813 patients in the pivotal controlled trials and the 1365 patients in the phase 2/3 clinical development program. The potential for secondary renal effects is also discussed. Effects on the urinary system are unusual for an antiepileptic drug, and reflect the unique mode of action of retigabine.

Abstract | Full Text | PDF


Onset of intractability and its course over time: The Dutch study of epilepsy in childhood.

Geerts A, Brouwer O, Stroink H, et al.
Volume 53, Issue 4, pp 741-751, April, 2012.

DOI: 10.1111/j.1528-1167.2012.03429.x

The view has grown up, partly fuelled by what many consider a recent ill-conceived definition of drug-resistant epilepsy, that intractability can be reliably defined by the early response (or lack thereof) to medication. In this study of 413 people with childhood onset epilepsy who were followed for a mean of 15 years, the authors found a large and unpredictable variation in time of onset, course, and duration of ‘intractability’.

They concluded that this variation represented the natural course of epilepsy rather than any effect of medication. The paper is an interesting contribution to this long-running debate, on a topic which has been written about for at least 150 years. Despite this long history, there remains fierce disagreement over how to define intractability and how to predict it.

The topic is important as many patients are distressed by the erroneous view that a failure to respond to initial therapy will mean inevitable chronic epilepsy. This study shows the complexity of patterns of epilepsy, and concludes wisely that a solid and all-encompassing definition of intractability remains to be established.

Abstract | Full Text | PDF


Home | Contact Us | Privacy & Security | Login | Sitemap

© 2012 International League Against Epilepsy